Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
03/1998
03/26/1998DE19706824C1 Plaster for transdermal drug delivery
03/26/1998CA2266412A1 Compositions containing cobalamin and amino acids
03/26/1998CA2266404A1 Phospholipid drug derivatives
03/26/1998CA2266388A1 Polyethyleneglycol conjugated nanoerythrosomes, method of making same and use thereof
03/26/1998CA2263495A1 Directly compressible lactitol and method
03/25/1998EP0831059A1 Mesoporous silica, process for the preparation thereof and use thereof
03/25/1998EP0830859A2 Polyetheresters copolymers as drug delivery matrices
03/25/1998EP0830381A1 Chitin hydrogels, methods of their production and use
03/25/1998EP0830380A1 Antigenic group b streptococcus type ii and type iii polysaccharide fragments having a 2, 5-anhydro-d-mannose terminal structure and conjugate vaccine thereof
03/25/1998EP0830149A1 Biocompatible hydroxyapatite formulations and uses therefor
03/25/1998EP0830147A1 Polymyxin conjugates
03/25/1998EP0830145A1 Formulations for lipophilic compounds
03/25/1998EP0830144A1 Water soluble, powder form compositions and applications thereof
03/25/1998EP0830142A1 Viral agent associated with mystery swine disease
03/25/1998EP0830138A1 Use of fibroblast growth factors to stimulate bone growth
03/25/1998EP0830137A1 Ionic molecular conjugates of n-acylated derivatives of poly(2-amino-2-deoxy-d-glucose) and polypeptides
03/25/1998EP0830132A1 Pharmaceutical composition containing tiagabine hydrochloride and the process for its preparation
03/25/1998EP0830128A1 Compositions and methods useful for inhibiting cell death and for delivering an agent into a cell
03/25/1998EP0830126A1 Stabilized pseudo-emulsions and their preparation process
03/25/1998EP0707473B1 Oral pharmaceutical compositions comprising a protein or peptide, an antibody and polymeric beads
03/25/1998EP0679094B1 Compounds for targeting
03/25/1998EP0564531B1 Enrichment method for variant proteins with altered binding properties
03/25/1998CN1177342A Novel cationic lipids and the use thereof
03/25/1998CN1177300A Enrofloxacine injection or infusion solutions
03/25/1998CN1177294A Water based topical cream contg. nitroglycerin, prepn. method therefor and use thereof
03/25/1998CN1177292A Liquid aqueous pharmaceutical compositions comprising sodium alginate and potassium bicarbonate
03/25/1998CN1176827A Method for preparing freeze-dried live vaccine for animal use
03/25/1998CN1176826A Cyclosporin-containing topical pharmaceutical compostion
03/24/1998US5731409 Polypeptides with type I collagen activity
03/24/1998US5731391 Fluid composition for physiological separations with enhanced resistance to inward migration of substances requiring accurate dosage monitoring
03/24/1998US5731356 Limiting growth of staphylococcus, candida, escherichia, and/or pseudomonas in anesthetic oil in water emulsion
03/24/1998US5731355 Pharmaceutical compositions of propofol and edetate
03/24/1998US5731349 Glycine
03/24/1998US5731316 Derivatives of camptothecin and methods of treating cancer using these derivatives
03/24/1998US5731303 Transdermal and trans-membrane delivery compositions
03/24/1998US5731302 Colloidal cellulose, hydrophilic thickener
03/24/1998US5731159 Heat stable receptor protein contacted with detectable antibodies
03/24/1998US5731007 Pharmaceutical composition for skin diseases
03/24/1998US5731006 Gastrointestinal mucosa-adherent granules, pharmaceutical preparations and a coating composition
03/24/1998US5731002 Antisecretory
03/24/1998US5731000 Stabilized pharmaceutical composition containing bupropion
03/24/1998US5730990 Non-antigenic amine derived polymers and polymer conjugates
03/24/1998US5730982 Therapeutic use of hypervariable region of monoclonal antibody M195 and constructs thereof
03/24/1998US5730975 Treatment of insulin resistance in obesity linked type II diabetes using antagonist to TNF-alpha function
03/24/1998US5730969 Method and compositions for solubilization and stabilization of polypeptides, especially proteins
03/24/1998US5730968 Amide-linked polyoxyalkylene glycols; cytotoxic agents; medical diagnosis, magnetic resonance imaging
03/24/1998CA1339775C Antibody 0.5b to hiv-i gp 120 modified with toxic substance
03/24/1998CA1339770C Mitotic inhibitor and method for preventing posterior lens capsule opacification after extracapsular extraction
03/20/1998CA2214892A1 Cosmetic composition containing a particular copolymer and use of the said copolymer in a cosmetic
03/19/1998WO1998011245A1 Sustained delivery device and methods of making and using the same
03/19/1998WO1998011218A1 Cxcr3 chemokine receptor, antibodies, nucleic acids, and methods of use
03/19/1998WO1998011208A1 Method for preparing a plasmid dna
03/19/1998WO1998011206A2 THERAPY FOR α-GALACTOSIDASE A DEFICIENCY
03/19/1998WO1998011126A1 Peptide prodrugs containing an alpha-hydroxyacid linker
03/19/1998WO1998011082A1 New amino alcohol derivatives, process for the production thereof and medicaments and reagents containing these compounds
03/19/1998WO1998011066A1 Polydithiocarbamate-containing macromolecules and the use thereof for therapeutic and diagnostic applications
03/19/1998WO1998010795A2 Tumor homing molecules, conjugates derived therefrom, and methods of using same
03/19/1998WO1998010794A2 Antineoplastic conjugates of transferrin, albumin and polyethylene glycol
03/19/1998WO1998010793A1 Formulations for topical use
03/19/1998WO1998010770A1 Oral compositions containing fluocinonide
03/19/1998WO1998010768A1 Antiviral compositions
03/19/1998WO1998010767A2 Use of quinazoline derivatives for the manufacture of a medicament in the treatment of hyperproliferative skin disorders
03/19/1998WO1998010762A2 Controlled release dosage form of r-(z)-alpha-methoxyimino-alpha-(1-azabicyclo2.2oct-c-yl)acetonitrile monohydrochloride
03/19/1998WO1998010754A1 Fast decomposing pellets
03/19/1998WO1998010753A1 Captopril tablets
03/19/1998WO1998010751A1 Spherical particle groups, process for preparing the same and spherical particulate pharmaceuticals using the same
03/19/1998WO1998010750A2 Nucleic acid particle delivery
03/19/1998WO1998010747A1 Immunomodulatory formulation
03/19/1998WO1998010746A1 Compositions and methods for topical application of therapeutic agents
03/19/1998WO1998010742A1 Composition base for topical therapeutic and cosmetic preparations
03/19/1998WO1998010651A1 Conjugates useful in the treatment of prostate cancer
03/19/1998WO1998010649A1 Biocompatible cationic detergents and uses therefor
03/19/1998WO1998006387A3 Oral composition comprising 5-aminosalicylic acid
03/19/1998WO1998001158A3 Haemoglobin-hydroxyethyl starch conjugates as oxygen carriers
03/19/1998WO1997042975A3 Chitosan related compositions for delivery of nucleic acids into a cell
03/19/1998DE19638045A1 Injektionsformulierungen von Avermectinen und Milbemycinen Injection formulations of avermectins and milbemycins
03/19/1998DE19637082A1 Schnellzerfallende Pellets Rapidly disintegrating pellets
03/19/1998DE19637043A1 Neue Aminoalkoholderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel und Reagenzien New amino alcohol derivatives, processes for their preparation and pharmaceutical compositions containing them and reagents
03/19/1998CA2266123A1 Method for preparing a plasmid dna
03/19/1998CA2266028A1 Oral compositions containing fluocinonide
03/19/1998CA2265933A1 Sustained delivery device and methods of making and using the same
03/19/1998CA2265877A1 Polydithiocarbamate-containing macromolecules and the use thereof for therapeutic and diagnostic applications
03/19/1998CA2265861A1 Antineoplastic conjugates of transferrin, albumin and polyethylene glycol
03/19/1998CA2265765A1 New amino alcohol derivatives, process for the production thereof and medicaments and reagents containing these compounds
03/19/1998CA2265661A1 Controlled release dosage form of r-(z)-alpha-methoxyimino-alpha-(1-azabicyclo2.2.2oct-c-yl)acetonitrile monohydrochloride
03/19/1998CA2265630A1 Use of quinazoline derivatives for the manufacture of a medicament in the treatment of hyperproliferative skin disorders
03/19/1998CA2265476A1 Conjugates useful in the treatment of prostate cancer
03/19/1998CA2265454A1 Peptide prodrugs containing an alpha-hydroxyacid linker
03/19/1998CA2237557A1 Composition base for topical therapeutic and cosmetic preparations
03/18/1998EP0828828A2 C-C CHEMOKINE RECEPTOR 3: CKP-3 OR Eos-L2
03/18/1998EP0828759A1 Process of high purity albumin production
03/18/1998EP0828517A1 Conjugates of folate and anti-effector cell antibodies
03/18/1998EP0828516A1 Skin permeation enhancer compositions using acyl lactylates
03/18/1998EP0828505A1 Use of angiotensin ii type 2 receptor agonists in tissue repair
03/18/1998EP0828500A1 Use of flavanolignanes for the preparation of medicaments with antiproliferative activity in uterus, ovary and breast
03/18/1998EP0828495A1 Stabilized solid dispersions of misoprostol
03/18/1998EP0828482A1 Cosmetic make-up compositions
03/18/1998EP0828481A1 Oral dosage composition for intestinal delivery and method of use of the same
03/18/1998EP0624097B1 Targeting radioactive immunoreagents
03/18/1998EP0532546B1 A pharmaceutical preparation containing n-glycofurols and n-ethylene glycols
1 ... 1471 1472 1473 1474 1475 1476 1477 1478 1479 1480 1481 1482 1483 1484 1485 1486 1487 1488 1489 1490 1491 ... 1712